
Agilent Technologies (A) Stock Forecast & Price Target
Agilent Technologies (A) Analyst Ratings
Bulls say
Agilent Technologies is uniquely positioned in the market as a leading life science and diagnostic company with a diverse range of customers, including the growing biopharmaceutical, chemical, and advanced materials end markets. With operations in the US and China, Agilent's geographic diversity and strong product cycle momentum, along with its large exposure to drug manufacturing and minimal academic/government drag, make it a strong investment choice. Additionally, the company's recent earnings beat and raised guidance support its potential for continued growth.
Bears say
Agilent Technologies is facing significant challenges, including already high market optimism and a reliance on organic growth and margin expansion that may not be achievable due to external factors. Additionally, the company's exposure to cyclical industries and regions, namely China, puts it at risk for potential volatility and challenges in demand. While Agilent has a strong presence in the life sciences and diagnostics market, it faces sustainability challenges and diverging stakeholder expectations on climate and diversity measures. Overall, the company's financials and operations suggest a rocky outlook with potential downside risks in the future.
This aggregate rating is based on analysts' research of Agilent Technologies and is not a guaranteed prediction by Public.com or investment advice.
Agilent Technologies (A) Analyst Forecast & Price Prediction
Start investing in Agilent Technologies (A)
Order type
Buy in
Order amount
Est. shares
0 shares